Skip to main content
. 2010 Aug;160(7):1690–1698. doi: 10.1111/j.1476-5381.2010.00838.x

Figure 7.

Figure 7

Effects of the MEK inhibitor U0126 (10 µM) on sorafenib (0.1 µM)-induced migration of different human bladder carcinoma cell lines (RT4, T24, J82). The quantitative analysis (means ± SEM) of five experiments are shown. *P < 0.05 versus control (anova /Bonferroni).

HHS Vulnerability Disclosure